Continued Use of 0.05% Atropine Over Time May Help Stall Myopia Progression
- Posted on: Sep 10 2024
- Leave a response
This paper discusses the 4th phase of the randomized controlled Low-Concentration Atropine for Myopia Progression 1 trial, which examines the efficacy and safety of various low-dose atropine concentrations for preventing pediatric myopia progression.
Source: AAO
Posted in: Uncategorized
